Review



s protein omicron variant  (BPS Bioscience)


Bioz Manufacturer Symbol BPS Bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    BPS Bioscience s protein omicron variant
    S Protein Omicron Variant, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s protein omicron variant/product/BPS Bioscience
    Average 94 stars, based on 1 article reviews
    s protein omicron variant - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    Miltenyi Biotec sars cov 2 spike protein omicron variant
    Sars Cov 2 Spike Protein Omicron Variant, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 spike protein omicron variant/product/Miltenyi Biotec
    Average 94 stars, based on 1 article reviews
    sars cov 2 spike protein omicron variant - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    96
    Sino Biological andsars cov 2 omicron variant s
    Andsars Cov 2 Omicron Variant S, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/andsars cov 2 omicron variant s/product/Sino Biological
    Average 96 stars, based on 1 article reviews
    andsars cov 2 omicron variant s - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    94
    BPS Bioscience s protein omicron variant
    S Protein Omicron Variant, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s protein omicron variant/product/BPS Bioscience
    Average 94 stars, based on 1 article reviews
    s protein omicron variant - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Antibodies-Online Inc s protein beta (b.1.351), alpha (b.1.1.7), omicron variants
    S Protein Beta (B.1.351), Alpha (B.1.1.7), Omicron Variants, supplied by Antibodies-Online Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s protein beta (b.1.351), alpha (b.1.1.7), omicron variants/product/Antibodies-Online Inc
    Average 90 stars, based on 1 article reviews
    s protein beta (b.1.351), alpha (b.1.1.7), omicron variants - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Sanyou Biopharmaceuticals Co Ltd sars-cov-2 s protein (omicron/b.1.1.529 variant)
    Sars Cov 2 S Protein (Omicron/B.1.1.529 Variant), supplied by Sanyou Biopharmaceuticals Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars-cov-2 s protein (omicron/b.1.1.529 variant)/product/Sanyou Biopharmaceuticals Co Ltd
    Average 90 stars, based on 1 article reviews
    sars-cov-2 s protein (omicron/b.1.1.529 variant) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    ACROBiosystems omicron variant trimer s protein (b.1.1.529)
    Omicron Variant Trimer S Protein (B.1.1.529), supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/omicron variant trimer s protein (b.1.1.529)/product/ACROBiosystems
    Average 90 stars, based on 1 article reviews
    omicron variant trimer s protein (b.1.1.529) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation the s protein of the omicron variant (b.1.1.529) (so; cat. no.: rp30121)
    The S Protein Of The Omicron Variant (B.1.1.529) (So; Cat. No.: Rp30121), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/the s protein of the omicron variant (b.1.1.529) (so; cat. no.: rp30121)/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    the s protein of the omicron variant (b.1.1.529) (so; cat. no.: rp30121) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    GenScript corporation s-protein rbd, omicron variant
    S Protein Rbd, Omicron Variant, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s-protein rbd, omicron variant/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    s-protein rbd, omicron variant - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    96
    Sino Biological sars cov 2 omicron variant s
    A Scheme for vaccination series and subsequent systems serology analysis. Participants who received two doses of the inactivated vaccine CoronaVac were boosted with the mRNA vaccine BNT162b2. As controls, the two-dose mRNA vaccine recipients were also analyzed. Sera were collected at various time points and systems serology assays were conducted (see Table for specific days of sample collections). B Spike- (left) and receptor binding domain (RBD) (right) specific IgG1 levels for <t>SARS-CoV-2</t> WT and early VOCs (Alpha and Beta) were quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) via Luminex systems serology. Y -axis represents the MFI of binding in arbitrary units (A.U.) of a specific antigen. Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 75 th percentile + 1.5 * interquartile range. C Same as ( B ), but for latter VOC (Gamma, Delta, and Omicron) of SARS-CoV-2 VOC. All samples were assayed in technical duplicates. Kruskal–Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. See also Supplementary Fig. . Source data are provided as a Source Data file.
    Sars Cov 2 Omicron Variant S, supplied by Sino Biological, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sars cov 2 omicron variant s/product/Sino Biological
    Average 96 stars, based on 1 article reviews
    sars cov 2 omicron variant s - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    Image Search Results


    A Scheme for vaccination series and subsequent systems serology analysis. Participants who received two doses of the inactivated vaccine CoronaVac were boosted with the mRNA vaccine BNT162b2. As controls, the two-dose mRNA vaccine recipients were also analyzed. Sera were collected at various time points and systems serology assays were conducted (see Table for specific days of sample collections). B Spike- (left) and receptor binding domain (RBD) (right) specific IgG1 levels for SARS-CoV-2 WT and early VOCs (Alpha and Beta) were quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) via Luminex systems serology. Y -axis represents the MFI of binding in arbitrary units (A.U.) of a specific antigen. Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 75 th percentile + 1.5 * interquartile range. C Same as ( B ), but for latter VOC (Gamma, Delta, and Omicron) of SARS-CoV-2 VOC. All samples were assayed in technical duplicates. Kruskal–Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

    doi: 10.1038/s41467-023-39189-8

    Figure Lengend Snippet: A Scheme for vaccination series and subsequent systems serology analysis. Participants who received two doses of the inactivated vaccine CoronaVac were boosted with the mRNA vaccine BNT162b2. As controls, the two-dose mRNA vaccine recipients were also analyzed. Sera were collected at various time points and systems serology assays were conducted (see Table for specific days of sample collections). B Spike- (left) and receptor binding domain (RBD) (right) specific IgG1 levels for SARS-CoV-2 WT and early VOCs (Alpha and Beta) were quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) via Luminex systems serology. Y -axis represents the MFI of binding in arbitrary units (A.U.) of a specific antigen. Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 75 th percentile + 1.5 * interquartile range. C Same as ( B ), but for latter VOC (Gamma, Delta, and Omicron) of SARS-CoV-2 VOC. All samples were assayed in technical duplicates. Kruskal–Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: SARS-CoV-2 Omicron Variant S , Sino Biological , 40589-V08H26.

    Techniques: Binding Assay, Luminex, Whisker Assay

    A – D FcR antibody binding towards WT SARS-CoV-2 Spike was quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) via Luminex systems serology. Y-axis represents the MFI of binding full-length WT SARS-CoV-2 Spike. Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 25th percentile + 1.5 * interquartile range. ( A ) FcγRIIA, ( B ) FcγRIIB, ( C ) FcγRIIIA, and ( D ) FcγRIIIB. E – H Same as ( A – D) , but for SARS-CoV-2 RBD. Note that Y -axis scales are not the same. All samples were assayed in technical duplicates. Kruskal-Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. The samples were assayed in technical duplicates. See also Supplementary Fig. for SARS-CoV-2 Nucleocapsid and control results. Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

    doi: 10.1038/s41467-023-39189-8

    Figure Lengend Snippet: A – D FcR antibody binding towards WT SARS-CoV-2 Spike was quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) via Luminex systems serology. Y-axis represents the MFI of binding full-length WT SARS-CoV-2 Spike. Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 25th percentile + 1.5 * interquartile range. ( A ) FcγRIIA, ( B ) FcγRIIB, ( C ) FcγRIIIA, and ( D ) FcγRIIIB. E – H Same as ( A – D) , but for SARS-CoV-2 RBD. Note that Y -axis scales are not the same. All samples were assayed in technical duplicates. Kruskal-Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. The samples were assayed in technical duplicates. See also Supplementary Fig. for SARS-CoV-2 Nucleocapsid and control results. Source data are provided as a Source Data file.

    Article Snippet: SARS-CoV-2 Omicron Variant S , Sino Biological , 40589-V08H26.

    Techniques: Binding Assay, Luminex, Whisker Assay

    A Spike-specific IgG1 levels were measured at peak immunogenicity following the two-dose CoronaVac vaccination series (lane 1), during waning periods (lanes 2 and 3), and after mRNA boost (lane 4) for SARS-CoV-2 VOC (color legend shown on right). The Y -axis represents the MFI of the Spike from the VOC. Shown are means (solid line) with SEM for each VOC in the corresponding color in the shaded region. B Same as ( A ), but for the receptor-binding domains (RBD) of SARS-CoV-2 VOC. C Heatmap representation of binding for full-length Spike by antibody-subclasses and -isotypes and Fcγ-receptor complexes. Shown on the left are the description of CoronaVac doses, the subsequent waning period, and mRNA-vaccine booster, and on the right are the SARS-CoV-2 VOC or WT. The scale bar is shown to the right of the heatmap and represents MFI over baseline values. The values in each region represent the mean of values from individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). D Same as ( C ), but for the RBD of WT SARS-CoV-2 and VOC. The samples were assayed in technical duplicates. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

    doi: 10.1038/s41467-023-39189-8

    Figure Lengend Snippet: A Spike-specific IgG1 levels were measured at peak immunogenicity following the two-dose CoronaVac vaccination series (lane 1), during waning periods (lanes 2 and 3), and after mRNA boost (lane 4) for SARS-CoV-2 VOC (color legend shown on right). The Y -axis represents the MFI of the Spike from the VOC. Shown are means (solid line) with SEM for each VOC in the corresponding color in the shaded region. B Same as ( A ), but for the receptor-binding domains (RBD) of SARS-CoV-2 VOC. C Heatmap representation of binding for full-length Spike by antibody-subclasses and -isotypes and Fcγ-receptor complexes. Shown on the left are the description of CoronaVac doses, the subsequent waning period, and mRNA-vaccine booster, and on the right are the SARS-CoV-2 VOC or WT. The scale bar is shown to the right of the heatmap and represents MFI over baseline values. The values in each region represent the mean of values from individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). D Same as ( C ), but for the RBD of WT SARS-CoV-2 and VOC. The samples were assayed in technical duplicates. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: SARS-CoV-2 Omicron Variant S , Sino Biological , 40589-V08H26.

    Techniques: Binding Assay

    A (Left) Antibody-dependent complement deposition (ADCD) activities measured in fluorescent arbitrary units (A.U.) against the WT SARS-CoV-2 Spike (left) and Omicron Spike were quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) and after mRNA-vaccine booster (lane 10). B Same as ( A ), but for antibody-dependent neutrophil phagocytosis (ADNP) measured in phagocytic A.U. C Same as ( A ) but for antibody-dependent monocytic cellular phagocytosis (ADCP) measured in phagocytic A.U. D Same as ( A ) but for the Primary natural killer (NK) cells activities measured for percent expression of MIP1b (top) and CD107a (bottom). Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 75th percentile + 1.5 * interquartile range. Note that Y-axis scales are not the same. All samples were assayed in technical quadruplicates with a minimum of three independent donors. Kruskal-Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

    doi: 10.1038/s41467-023-39189-8

    Figure Lengend Snippet: A (Left) Antibody-dependent complement deposition (ADCD) activities measured in fluorescent arbitrary units (A.U.) against the WT SARS-CoV-2 Spike (left) and Omicron Spike were quantified in the baseline (prior to immunization, white, lane 1), 1- and 2-dose BNT162b2 mRNA (blue, lanes 2 and 3, waning periods in lanes 4 and 5), 1- and 2-dose CoronaVac (gray, lanes 6 and 7, waning periods in lanes 8 and 9) and after mRNA-vaccine booster (lane 10). B Same as ( A ), but for antibody-dependent neutrophil phagocytosis (ADNP) measured in phagocytic A.U. C Same as ( A ) but for antibody-dependent monocytic cellular phagocytosis (ADCP) measured in phagocytic A.U. D Same as ( A ) but for the Primary natural killer (NK) cells activities measured for percent expression of MIP1b (top) and CD107a (bottom). Shown are box and whiskers, along with individual data points, which represent the mean of individual participants from each vaccine group (BNT162b2, n = 15 and CoronaVac, n = 34). The whisker above the box plot extends from the top quartile to the highest actual value that is within the 75th percentile + 1.5 * interquartile range. The whisker below the box plot extends from the lower quartile to the lowest actual value that is within 75th percentile + 1.5 * interquartile range. Note that Y-axis scales are not the same. All samples were assayed in technical quadruplicates with a minimum of three independent donors. Kruskal-Wallis test was used for all panels (* p < 0.05 and ** p < 0.01). All Kruskal–Wallis tests were two-sided, and no adjustments were made for multiple comparisons. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: SARS-CoV-2 Omicron Variant S , Sino Biological , 40589-V08H26.

    Techniques: Expressing, Whisker Assay

    List of reagents and resources used in this study

    Journal: Nature Communications

    Article Title: Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination

    doi: 10.1038/s41467-023-39189-8

    Figure Lengend Snippet: List of reagents and resources used in this study

    Article Snippet: SARS-CoV-2 Omicron Variant S , Sino Biological , 40589-V08H26.

    Techniques: Binding Assay, Variant Assay, Chromatography, Software, Luminex